{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:09:14Z","timestamp":1778922554506,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173208"],"award-info":[{"award-number":["82173208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473380"],"award-info":[{"award-number":["82473380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["24JCYBJC00700"],"award-info":[{"award-number":["24JCYBJC00700"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xcrm.2025.102434","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T01:35:00Z","timestamp":1762392900000},"page":"102434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"Yuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aomei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3345-8005","authenticated-orcid":false,"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102434_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2025.102434_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2025.102434_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-med-051718-013524","article-title":"Precision Management of Advanced Non-Small Cell Lung Cancer","volume":"71","author":"Yang","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.xcrm.2025.102434_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102434_bib6","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor Mutational Burden and Response Rate to PD-1 Inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102434_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-Line Immunotherapy for Non-Small-Cell Lung Cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102434_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107694","article-title":"Combination therapy with PD-1\/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms","volume":"219","author":"Huang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2025.102434_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","article-title":"Resistance Mechanisms to Anti-PD Cancer Immunotherapy","volume":"40","author":"Vesely","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102434_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","article-title":"Immune mechanisms of toxicity from checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(21)00711-7","article-title":"Overcoming immunotherapy resistance in NSCLC","volume":"23","author":"MacManus","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2025.102434_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1470-2045(19)30167-6","article-title":"Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"West","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2025.102434_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12943-020-01260-z","article-title":"Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook","volume":"19","author":"Horvath","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102434_bib15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41467-023-36892-4","article-title":"CDK4\/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy","volume":"14","author":"Bai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102434_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cell.2020.03.008","article-title":"Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer","volume":"181","author":"Ruscetti","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102434_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccell.2016.06.016","article-title":"Tumor-Associated Neutrophils Show Phenotypic and Functional Divergence in Human Lung Cancer","volume":"30","author":"Saha","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/imr.13176","article-title":"N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology","volume":"314","author":"Antuamwine","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.xcrm.2025.102434_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41467-020-20733-9","article-title":"Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung","volume":"12","author":"Tyagi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102434_bib23","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib24","doi-asserted-by":"crossref","first-page":"E10578","DOI":"10.1073\/pnas.1710877114","article-title":"Anti-SIRP\u03b1 antibody immunotherapy enhances neutrophil and macrophage antitumor activity","volume":"114","author":"Ring","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102434_bib25","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1172\/JCI97570","article-title":"Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity","volume":"128","author":"Chen","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102434_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102434_bib27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.immuni.2016.01.024","article-title":"MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade","volume":"44","author":"Ebert","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102434_bib28","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.7150\/thno.37218","article-title":"Small molecules as theranostic agents in cancer immunology","volume":"9","author":"Li","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2025.102434_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/2159-8290.CD-15-0894","article-title":"Targeting CDK4 and CDK6: From Discovery to Therapy","volume":"6","author":"Sherr","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102434_bib30","doi-asserted-by":"crossref","first-page":"69493","DOI":"10.18632\/oncotarget.17778","article-title":"Preclinical characterization of abemaciclib in hormone receptor positive breast cancer","volume":"8","author":"Torres-Guzm\u00e1n","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2025.102434_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102434_bib32","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1158\/2159-8290.CD-20-1554","article-title":"CDK4\/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory","volume":"11","author":"Lelliott","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102434_bib33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/1535-7163.MCT-15-0775","article-title":"Preclinical Characterization of G1T28: A Novel CDK4\/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression","volume":"15","author":"Bisi","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2025.102434_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3986","article-title":"Transient CDK4\/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion","volume":"9","author":"He","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102434_bib35","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/annonc\/mdz278","article-title":"Myelopreservation with the CDK4\/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib\/randomized phase II trial","volume":"30","author":"Weiss","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2025.102434_bib36","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S1470-2045(19)30616-3","article-title":"Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial","volume":"20","author":"Tan","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2025.102434_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000847","article-title":"CDK4\/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy","volume":"8","author":"Lai","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6493","article-title":"Deterministic reprogramming of neutrophils within tumors","volume":"383","author":"Ng","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102434_bib39","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1172\/JCI77053","article-title":"Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer","volume":"124","author":"Eruslanov","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102434_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ccell.2016.06.001","article-title":"Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer","volume":"30","author":"Singhal","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib41","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","article-title":"T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants","volume":"186","author":"Hirschhorn","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib42","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.aas9090","article-title":"NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination","volume":"362","author":"Ruscetti","year":"2018","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.xcrm.2025.102434_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer - role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102434_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41573-024-01074-4","article-title":"Senescence as a therapeutic target in cancer and age-related diseases","volume":"24","author":"McHugh","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102434_bib45","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Reprogramming cellular senescence in the tumor microenvironment augments cancer immunotherapy through multifunctional nanocrystals","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102434_bib46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of Cellular Senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102434_bib47","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0145-2023","article-title":"CDK4\/6 inhibitors in lung cancer: current practice and future directions","volume":"33","author":"Lv","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.xcrm.2025.102434_bib48","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/jnci\/djy114","article-title":"Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome","volume":"110","author":"Fischer","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.xcrm.2025.102434_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1083\/jcb.201212110","article-title":"Lysosome-mediated processing of chromatin in senescence","volume":"202","author":"Ivanov","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102434_bib50","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/emboj.2011.69","article-title":"p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype","volume":"30","author":"Freund","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2025.102434_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS-STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2025.102434_bib52","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","article-title":"Cellular functions of cGAS-STING signaling","volume":"33","author":"Chen","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102434_bib53","doi-asserted-by":"crossref","first-page":"9169","DOI":"10.1073\/pnas.1403565111","article-title":"DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin","volume":"111","author":"Ayrapetov","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102434_bib54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102434_bib55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cytogfr.2014.06.006","article-title":"The mechanism of double-stranded DNA sensing through the cGAS-STING pathway","volume":"25","author":"Shu","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.xcrm.2025.102434_bib56","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-025-02380-0","article-title":"Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib57","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cell.2019.05.047","article-title":"Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors","volume":"178","author":"Ponzetta","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib58","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102434_bib60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccell.2023.12.005","article-title":"Interferon-stimulated neutrophils as a predictor of immunotherapy response","volume":"42","author":"Benguigui","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib61","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","article-title":"A neutrophil response linked to tumor control in immunotherapy","volume":"186","author":"Gungabeesoon","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib64","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2025.102434_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1232221","article-title":"Tumor-associated neutrophils display a distinct N1 profile following TGF\u03b2 modulation: A transcriptomics analysis of pro- vs. antitumor TANs","volume":"5","author":"Shaul","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2025.102434_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092406","article-title":"Current Understanding of the Neutrophil Transcriptome in Health and Disease","volume":"10","author":"Garratt","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2025.102434_bib65","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102434_bib66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12943-024-02179-5","article-title":"Current trends in sensitizing immune checkpoint inhibitors for cancer treatment","volume":"23","author":"Wei","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib67","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102434_bib68","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s43018-023-00612-0","article-title":"IL-2R\u03b1-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25(+)CD8(+) T cells","volume":"4","author":"Wu","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib69","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.21.00174","article-title":"Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score \u2265 50","volume":"39","author":"Reck","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102434_bib70","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jtho.2021.03.028","article-title":"Prevalence and Heterogeneity of PD-L1 Expression by 22C3 Assay in Routine Population-Based and Reflexive Clinical Testing in Lung Cancer","volume":"16","author":"Hwang","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.xcrm.2025.102434_bib71","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102434_bib72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2159-8290.CD-17-0915","article-title":"CDK4\/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation","volume":"8","author":"Deng","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102434_bib73","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","article-title":"Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network","volume":"133","author":"Kuilman","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib74","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1101\/gad.343129.120","article-title":"Senescence and the SASP: many therapeutic avenues","volume":"34","author":"Birch","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2025.102434_bib75","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05505","article-title":"Recurrent turnover of senescent cells during regeneration of a complex structure","volume":"4","author":"Yun","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2025.102434_bib76","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102434_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.102016","article-title":"Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype","volume":"24","author":"Hao","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2025.102434_bib78","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102434_bib79","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8657","article-title":"cGAS in action: Expanding roles in immunity and inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102434_bib80","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1158\/0008-5472.CAN-18-1003","article-title":"PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness","volume":"79","author":"Shen","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102434_bib81","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gl\u00fcck","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102434_bib82","article-title":"IRF3 activates RB to authorize cGAS-STING-induced senescence and mitigate liver fibrosis","volume":"10","author":"Wu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102434_bib83","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","article-title":"Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity","volume":"183","author":"Kalafati","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib84","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/ijc.29945","article-title":"Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human","volume":"138","author":"Andzinski","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102434_bib85","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102434_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207650","article-title":"The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma","volume":"10","author":"He","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2025.102434_bib87","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1038\/s41467-021-24591-x","article-title":"Fc\u03b3R engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity","volume":"12","author":"Mysore","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102434_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf8748","article-title":"Neutrophil-intrinsic TNF receptor signaling orchestrates host defense against Staphylococcus aureus","volume":"9","author":"Youn","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102434_bib89","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood.V95.12.3804.012k31_3804_3808","article-title":"Synergistic induction of HLA class I expression by RelA and CIITA","volume":"95","author":"Girdlestone","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102434_bib90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CJI.0000000000000335","article-title":"TNF-a Is a Potent Stimulator of Tc9-Cell Differentiation","volume":"43","author":"Yang","year":"2020","journal-title":"J. Immunother."},{"key":"10.1016\/j.xcrm.2025.102434_bib91","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41419-021-03837-y","article-title":"PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway","volume":"12","author":"Han","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2025.102434_bib92","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2025.102434_bib93","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102434_bib94","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102434_bib95","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102434_bib96","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","article-title":"Single-cell transcriptional diversity is a hallmark of developmental potential","volume":"367","author":"Gulati","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.xcrm.2025.102434_bib97","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102434_bib98","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS A J. Integr. Biol."},{"key":"10.1016\/j.xcrm.2025.102434_bib99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2025.102434_bib100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125005075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125005075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:20:15Z","timestamp":1778919615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125005075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666379125005075"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102434","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102434"}}